It is known that endothelial dysfunction is present in the patients who are detected with SCF.3 Nebivolol (Vasoxen 5 mg tablets), a third-generation beta-blocker agent, may improve endothelial functions in these patients. The gene discussed is KITLG; the disease is endothelial dysfunction.